Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Predictors of response to biologic therapies in rheumatoid arthritis].

Reumatologia clinica - 1 Jan 2000

Chaves Chaparro Lara M, Salvatierra Ossorio Juan, Raya Álvarez Enrique

Abstract excerpt

The advent of biological therapies has revolutionized the management of rheumatoid arthritis, demonstrating effectiveness in controlling clinical and radiological damage. However, 20 to 40% of the patients will not respond to these therapies, which are associated to a very high cost. In addition, non-responder patients are exposed to possible adverse effects. For these reasons, we need to identify predictors of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibody Specificity
Share to Autoantigens
Share to Cartilage Oligomeric Matrix Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Citrulline

Share to Major Histocompatibility Complex

Share to Matrilin Proteins

Share to Proteome

Share to Rheumatoid Factor

Source

Identifiers

PMID: 21794800
DOI: 10.1016/j.reuma.2010.11.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Predictors of response to biologic therapies in rheumatoid arthritis].PMID 21794800Read ↗

Predictive factors of response to biological disease modifying antirheumatic drugs: towards personalized medicine.Semantic proximity Read ↗

Prediction of Response to Targeted Treatment in Rheumatoid Arthritis.Semantic proximity Read ↗

Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and PharmacogeneticsSemantic proximity Read ↗

Can rheumatoid arthritis responsiveness to methotrexate and biologics be predicted?Semantic proximity Read ↗

[Susceptibility genes in rheumatoid arthritis].Semantic proximity Read ↗

[State-of-the-art immune genetic and immune biological aspects of rheumatoid arthritis].Semantic proximity Read ↗

[Current studies on susceptibility genes in rheumatoid arthritis].Semantic proximity Read ↗

Pharmacogenomics of biological treatment in rheumatoid arthritis.Semantic proximity Read ↗

Polymorphisms Involved in Response to Biological Agents Used in Rheumatoid Arthritis.Semantic proximity Read ↗

Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.Semantic proximity Read ↗

Genetic and Genomic Markers of Anti-TNF Treatment Response in Rheumatoid ArthritisSemantic proximity Read ↗

Genetic and genomic predictors of anti-TNF response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.